CHEMED CORP（CHE）内部人交易：高管与董事近期交易
过去 18 个月，共有 14 位内部人为 CHEMED CORP（CHE）报告了 70 笔 Form 4 交易（最近一笔 2026-10-01）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-01 | LEE SPENCER S | executive vice president | 买入 | 12,099 | $5.4M |
| 2026-10-01 | LEE SPENCER S | executive vice president | 卖出 | 11,160 | $5.7M |
| 2026-09-30 | MCNAMARA KEVIN J | president and CEO | 卖出 | 2,000 | $1.0M |
| 2026-09-29 | HUTTON THOMAS C | vice president | 买入 | 4,629 | $2.1M |
| 2026-09-29 | HUTTON THOMAS C | vice president | 卖出 | 4,270 | $2.2M |
| 2026-09-21 | MCNAMARA KEVIN J | president and CEO | 卖出 | 2,000 | $1.0M |
| 2026-08-24 | LEE SPENCER S | executive vice president | 卖出 | 1,000 | $541,040 |
| 2026-08-24 | MCNAMARA KEVIN J | president and CEO | 卖出 | 2,000 | $1.1M |
| 2026-08-10 | Judkins Brian C | VP and Chief Legal Officer | 买入 | 6,786 | $3.0M |
| 2026-08-10 | Judkins Brian C | VP and Chief Legal Officer | 卖出 | 5,878 | $3.2M |
| 2026-08-06 | Wherley Joel L | CEO - Vitas Healthcare | 买入 | 2,599 | $1.2M |
| 2026-08-06 | Wherley Joel L | CEO - Vitas Healthcare | 卖出 | 2,270 | $1.2M |
| 2026-08-04 | MCNAMARA KEVIN J | president and CEO | 买入 | 2,001 | $891,145 |
| 2026-08-04 | MCNAMARA KEVIN J | president and CEO | 卖出 | 19,802 | $10.5M |
| 2026-08-04 | MCNAMARA KEVIN J | president and CEO | 卖出 | 2,000 | $1.1M |
| 2026-08-03 | GRACE PATRICK P | 董事 | 卖出 | 190 | $101,080 |
| 2026-06-10 | LINDELL ANDREA R | 董事 | 卖出 | 1,347 | $602,554 |
| 2026-05-29 | WALSH GEORGE J III | 董事 | 卖出 | 500 | $218,915 |
| 2026-05-19 | McCarthy Eileen P | 董事 | 买入 | 386 | $170,137 |
| 2026-05-19 | WALSH GEORGE J III | 董事 | 买入 | 386 | $170,137 |
| 2026-05-19 | Mount John Meredith Jr. | 董事 | 买入 | 386 | $170,137 |
| 2026-05-19 | LINDELL ANDREA R | 董事 | 买入 | 386 | $170,137 |
| 2026-05-19 | Heaney Christopher J | 董事 | 买入 | 386 | $170,137 |
| 2026-05-19 | DeLyons Ron | 董事 | 买入 | 386 | $170,137 |
| 2026-05-19 | GRACE PATRICK P | 董事 | 买入 | 386 | $170,137 |
来源：SEC Form 4 申报文件 · 截至 2026-10-01